Ebola Virus Vaccine
cAdVax-based bivalent Ebola vaccine induces immunity against Sudan and Zaire Ebola species
Published in Vaccine Weekly, May 10th, 2006
"Ebola virus (EBOV) causes a severe hemorrhagic fever for which there are currently no vaccines or effective treatments. While lethal human outbreaks have so far been restricted to sub-Saharan Africa, the potential exploitation of EBOV as a biological weapon cannot be ignored," note researchers in the United States. "Two species of EBOV, Sudan ebolavirus (SEBOV) and Zaire ebolavirus (ZEBOV), have been responsible for all of the deadly human outbreaks resulting from this virus. Therefore, it is important to develop a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-05-10)
More Articles from Vaccine Weekly
- HIV/AIDS Vaccine
Robust HIV-specific immune responses were induced by DNA vaccine plus vaccinia virus boost - Tuberculosis Vaccine
Mycobacterium bovis BCG expressing SIV Gag protein induces immune responses - Vaccinia Virus Vaccine
Vaccinia virus mutated in envelope proteins A33R and B5R are immunogenic - Virology
Chimeric SIN/VEE viruses clear Venezuelan equine encephalitis virus from brain - Allergy & Immunology
IgG binding plant N-glycans were generated in rabbits but not in mice - Allergy & Immunology
NIH research may lead to new approaches to enhanced immune responses - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
